| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.16B | 23.61B | 21.78B | 20.36B | 18.62B | 17.55B |
| Gross Profit | 6.28B | 5.69B | 5.33B | 4.67B | 4.32B | 3.70B |
| EBITDA | 3.32B | 2.63B | 2.43B | 2.31B | 2.15B | 2.00B |
| Net Income | 2.35B | 1.86B | 1.70B | 1.59B | 1.50B | 1.53B |
Balance Sheet | ||||||
| Total Assets | 21.98B | 23.09B | 22.03B | 20.28B | 18.61B | 17.75B |
| Cash, Cash Equivalents and Short-Term Investments | 9.04B | 8.82B | 7.50B | 6.81B | 7.64B | 7.56B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 5.31B | 6.37B | 5.91B | 5.48B | 4.97B | 5.20B |
| Stockholders Equity | 16.67B | 16.72B | 16.12B | 14.79B | 13.63B | 12.54B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.70B | 1.71B | 1.30B | 910.00M | 2.23B |
| Operating Cash Flow | 0.00 | 1.82B | 1.94B | 1.43B | 991.00M | 2.30B |
| Investing Cash Flow | 0.00 | -931.00M | -470.00M | -1.61B | -1.64B | -574.00M |
| Financing Cash Flow | 0.00 | -1.27B | -474.00M | -458.00M | -463.00M | -427.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥26.25B | 12.24 | ― | 0.82% | ― | ― | |
77 Outperform | ¥29.89B | 12.67 | ― | 2.93% | 11.53% | 23.23% | |
71 Outperform | ¥26.58B | 24.88 | ― | 2.35% | 9.91% | 61.65% | |
68 Neutral | ¥22.15B | 15.25 | ― | ― | 14.28% | -30.60% | |
64 Neutral | ¥36.08B | 20.10 | ― | ― | 27.97% | -5.25% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
49 Neutral | ¥25.82B | 39.28 | ― | ― | 20.84% | 10.41% |